Comparison of the effects of remimazolam and propofol on agitation during the awakening period in elderly patients undergoing hip replacement: a clinical, randomized, controlled study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068101

Enrollment

Unknown

Registered

2023-02-07

Start date

2023-02-07

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Remimazolam group:Infusion of remimazolam

Propofol group:Infusion of propofol

Eligibility

Sex/Gender

All

Age

60 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 60-75 years; 2. ASA ?-? level; 3. BMI 18-28 kg/m^2; 4. Have independent communication skills.

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of heart, lung, liver and kidney; 2. Previous history of mental illness or delirium; 3. History of taking sedative and analgesic drugs within the past 1 month; 4. History of surgery in recent 3 months; 5. Massive intraoperative bleeding, bleeding volume greater than 1000ml; 6. Refuse to participate in the study.

Design outcomes

Primary

Measure	Time frame
Incidence of agitation during the waking period;	—

Secondary

Measure	Time frame
Hemodynamic parameters;Adverse reactions during awakening;	—

Countries

China

Contacts

Public ContactXu Siqi

Anqing Municipal Hospital

errtg555@163.com+86 138 6519 2106

Outcome results